[123I]MNI-168

N/A

Report date: 2025/11/24 11:49:34
NME

Base Information

Drug Name[123I]MNI-168
Drug Alias NameMNI-168
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 123I +[5] 
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInst For Neurodegenerative Disorders
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Institute For Neurodegenerative Disorders Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A